Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) Research & Development (2016 - 2022)

Inogen (INGN) has disclosed Research & Development for 10 consecutive years, with $6.1 million as the latest value for Q2 2022.

  • On a quarterly basis, Research & Development rose 47.08% to $6.1 million in Q2 2022 year-over-year; TTM through Jun 2022 was $18.6 million, a 27.59% increase, with the full-year FY2021 number at $16.6 million, up 17.73% from a year prior.
  • Research & Development was $6.1 million for Q2 2022 at Inogen, up from $4.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6.1 million in Q2 2022 to a low of $1.4 million in Q1 2018.
  • A 5-year average of $3.1 million and a median of $3.4 million in 2020 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: dropped 17.3% in 2019, then surged 124.11% in 2020.
  • Inogen's Research & Development stood at $1.7 million in 2018, then surged by 108.27% to $3.6 million in 2019, then grew by 1.27% to $3.7 million in 2020, then increased by 27.49% to $4.7 million in 2021, then rose by 29.46% to $6.1 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Research & Development are $6.1 million (Q2 2022), $4.7 million (Q4 2021), and $3.8 million (Q3 2021).